FTRE
Price
$15.63
Change
+$0.27 (+1.76%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
1.49B
75 days until earnings call
Intraday BUY SELL Signals
SGMT
Price
$6.86
Change
+$0.07 (+1.03%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
444M
77 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FTRE vs SGMT

Header iconFTRE vs SGMT Comparison
Open Charts FTRE vs SGMTBanner chart's image
FTRE vs SGMT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
FTRE vs. SGMT commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Hold and SGMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (FTRE: $15.36 vs. SGMT: $6.79)
Brand notoriety: FTRE and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 103% vs. SGMT: 49%
Market capitalization -- FTRE: $1.49B vs. SGMT: $444M
FTRE [@Biotechnology] is valued at $1.49B. SGMT’s [@Biotechnology] market capitalization is $444M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileSGMT’s FA Score has 0 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • SGMT’s FA Score: 0 green, 5 red.
According to our system of comparison, both FTRE and SGMT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 5 TA indicator(s) are bullish while SGMT’s TA Score has 5 bullish TA indicator(s).

  • FTRE’s TA Score: 5 bullish, 4 bearish.
  • SGMT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SGMT is a better buy in the short-term than FTRE.

Price Growth

FTRE (@Biotechnology) experienced а +16.19% price change this week, while SGMT (@Biotechnology) price change was -5.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

FTRE is expected to report earnings on Aug 17, 2026.

SGMT is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FTRE($1.49B) has a higher market cap than SGMT($444M). SGMT YTD gains are higher at: 14.696 vs. FTRE (-10.957). SGMT has higher annual earnings (EBITDA): -64.32M vs. FTRE (-280.8M). FTRE has more cash in the bank: 148M vs. SGMT (117M). SGMT has less debt than FTRE: SGMT (115K) vs FTRE (1.12B). FTRE has higher revenues than SGMT: FTRE (2.71B) vs SGMT (0).
FTRESGMTFTRE / SGMT
Capitalization1.49B444M336%
EBITDA-280.8M-64.32M437%
Gain YTD-10.95714.696-75%
P/E RatioN/AN/A-
Revenue2.71B0-
Total Cash148M117M126%
Total Debt1.12B115K972,174%
TECHNICAL ANALYSIS
Technical Analysis
FTRESGMT
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 14 days ago
84%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
FTRE
Daily Signal:
Gain/Loss:
SGMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CSD138.640.47
+0.34%
Invesco S&P Spin-Off ETF
ATTR94.45N/A
N/A
Arin Tactical Tail Risk ETF
XIDE30.31N/A
-0.02%
FT Vest U.S. Eq Buf & PrmIncETF-Dec
MODL51.09-0.09
-0.17%
VictoryShares WestEnd U.S. Sector ETF
NVDB35.68-0.39
-1.08%
ProShares Ultra NVDA

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with BEAM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
-2.54%
BEAM - FTRE
40%
Loosely correlated
-7.00%
RXRX - FTRE
40%
Loosely correlated
-4.62%
NTLA - FTRE
38%
Loosely correlated
-4.37%
MRVI - FTRE
36%
Loosely correlated
+2.11%
TECH - FTRE
36%
Loosely correlated
-2.00%
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with GOSS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
-5.56%
GOSS - SGMT
37%
Loosely correlated
+1.01%
VIR - SGMT
34%
Loosely correlated
-3.21%
FTRE - SGMT
34%
Loosely correlated
-2.54%
CRBU - SGMT
33%
Poorly correlated
-4.32%
AGIO - SGMT
32%
Poorly correlated
-5.36%
More